Summary
Medtronic plc (MDT) has filed an 8-K detailing the pricing and issuance of new senior notes, alongside the redemption of existing notes. The company will issue €1.5 billion in aggregate principal amount of new senior notes, consisting of €750 million due 2030 at 2.950% and €750 million due 2045 at 4.200%. These new notes are guaranteed by Medtronic plc and Medtronic Luxco. The net proceeds from this offering are earmarked to repay Medtronic Luxco's maturing 0.000% and 2.625% Senior Notes due 2025. Specifically, Medtronic Luxco has elected to redeem all outstanding €500 million of its 2.625% Senior Notes due 2025 on September 29, 2025, at a price of 100% of the principal plus accrued interest. The redemption is contingent on the successful completion of the new notes issuance. This refinancing activity was previously factored into Medtronic's reiterated fiscal year 2026 adjusted earnings per share guidance.
Key Highlights
- 1Medtronic plc priced a new offering of €1.5 billion in Senior Notes, split between €750 million due 2030 (2.950% coupon) and €750 million due 2045 (4.200% coupon).
- 2Proceeds from the new note issuance will be used to repay existing Medtronic Luxco Senior Notes maturing in 2025.
- 3Medtronic Luxco has initiated the redemption process for its entire €500 million of 2.625% Senior Notes due 2025.
- 4The redemption of the existing notes is scheduled for September 29, 2025, at par plus accrued interest.
- 5The redemption is conditional on the successful completion of the new debt issuance by the redemption date.
- 6The company reiterated its fiscal year 2026 adjusted earnings per share guidance, indicating these financing activities were anticipated.
- 7New notes are fully and unconditionally guaranteed by Medtronic plc and Medtronic Luxco.